New York — Certain Warburg Pincus entities collectively sold 19,102,952 shares of Sotera Health Co (NASDAQ:SHC) common stock on May 13, 2026, in an underwritten public secondary offering.
The shares were sold at $15.168 each, totaling approximately $289,753,575.
Following this transaction, the Warburg Pincus entities no longer hold any Sotera Health shares.
Sotera Health recently reported strong Q1 2026 results with EPS of $0.18 beating estimates of $0.17, and revenue of $280.05 million surpassing expectations of $270.78 million.
Despite the positive earnings, Sotera Health stock fell in premarket trading.
Wolfe Research lowered its price target to $19 from $20 but maintained an Outperform rating.
